Publications

Home
Publications

Continuous Glucose Monitoring for Prediabetes - Roles, Evidence, and Gaps
Published on 2025-05-23 First Author Salwa J Zahalka
Heart failure with preserved ejection fraction therapeutics: in search of the pillars
Published on 2025-05-21 First Author Abdelghani El Rafei
Preserving Trial Endpoint Specificity and Cause of Death Attribution in Cardiovascular Trials: Insights From MARINER
Published on 2025-05-13 First Author Shea E Hogan
Dexcom G7 Accuracy and Reproducibility in the Intensive Care Unit
Published on 2025-05-13 First Author Jesica D Baran
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
Published on 2025-05-08 First Author Stephen J Nicholls
Research priorities for peripheral artery disease: A statement from the Society for Vascular Medicine
Published on 2025-05-01 First Author Mary M McDermott
Prescription of aspirin plus low-dose rivaroxaban in patients with peripheral artery disease after lower-extremity revascularization
Published on 2025-04-30 First Author Mario Enrico Canonico
Hypertension in atherosclerotic cardiovascular disease: insights into epidemiology, management strategies, and outcomes
Published on 2025-04-30 First Author Prerna Gupta
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population
Published on 2025-04-15 First Author Rahul Aggarwal
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence
Published on 2025-04-14 First Author Mario Enrico Canonico
Virta Intervention in CommuniTies in ColORado (VICTOR) Pilot Study to Improve Diabetes and Cardiovascular Risk in Rural Communities - Primary Results
Published on 2025-04-10 First Author Cecilia C Low Wang
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
Published on 2025-04-07 First Author P Gabriel Steg
Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2025-04-07 First Author Heather L Gornik
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Published on 2025-04-01 First Author Marc P Bonaca
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial
Published on 2025-03-21 First Author R Kevin Rogers
Predictors of venous thromboembolic events in hospitalized patients with COVID-19
Published on 2025-03-11 First Author Giovanni Scimeca
Apolipoprotein C3, triglycerides, and cardiovascular risk in optimally treated ACS patients: The critical role of mediation analysis and implications for precision primary prevention: Reply
Published on 2025-03-10 First Author Gregory G Schwartz
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial
Published on 2025-02-19 First Author Rahul Aggarwal
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer
Published on 2025-02-19 First Author Marc P Bonaca
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Published on 2025-02-17 First Author Rahul Aggarwal
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Published on 2025-02-16 First Author Clara I Saldarriaga
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome
Published on 2025-02-08 First Author Gregory G Schwartz
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials
Published on 2025-02-07 First Author Sina Rashedi
Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial
Published on 2025-02-06 First Author Gregory G Schwartz
Post-walking exercise skeletal muscle perfusion and energetics in patients with symptomatic lower extremity peripheral artery disease
Published on 2025-01-31 First Author Sanjay Divakaran
Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution
Published on 2025-01-29 First Author Doron Zahger
Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial
Published on 2025-01-27 First Author Connie N Hess
Reply: Where the Definition of Fragility Came From and Where It Will Go
Published on 2025-01-22 First Author Mario Enrico Canonico
Multidisciplinary Management of Chronic Limb Threatening Ischemia
Published on 2024-12-18 First Author Sivan Naveh
Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES
Published on 2024-12-17 First Author Gregory P Geba
Relationship Between Left Ventricular Ejection Fraction and ICD-10 Codes Among Patients Hospitalized With Heart Failure
Published on 2024-12-17 First Author Ty J Gluckman
Rationale and Design of a Study to Assess the Engagement and Usefulness of the Care4Today Connect Digital Health Application for Disease Management in Coronary Artery Disease and Peripheral Artery Disease (iPACE-CVD Study)
Published on 2024-12-12 First Author Dhanunjaya Lakkireddy
Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study
Published on 2024-11-21 First Author Irl B Hirsch
Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial
Published on 2024-11-18 First Author Steven E Nissen
Addressing Knowledge Gaps in Patients With High-Risk Peripheral Artery Disease
Published on 2024-11-11 First Author R Kevin Rogers
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
Published on 2024-10-30 First Author Yogesh N V Reddy
Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making
Published on 2024-10-28 First Author Judith Hsia
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years
Published on 2024-10-26 First Author Neil A Goldenberg
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes
Published on 2024-10-18 First Author Marc P Bonaca
Is it time to get SIRIUS about in silico modelling of cardiovascular outcomes trials?
Published on 2024-10-08 First Author Marc P Bonaca
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
Published on 2024-09-11 First Author Ankeet S Bhatt
Trends in patient characteristics and mortality among Medicare patients diagnosed with peripheral artery disease
Published on 2024-09-09 First Author Xavier Fowler
Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions
Published on 2024-09-08 First Author Mario Enrico Canonico
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome
Published on 2024-09-04 First Author Doron Zahger
A Novel Urology Preliminary Residency Curriculum Within a Department of Surgery for Unmatched Applicants
Published on 2024-09-02 First Author Tad A Manalo
Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement
Published on 2024-08-28 First Author Marc P Bonaca
Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization
Published on 2024-08-21 First Author Mario Enrico Canonico
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials
Published on 2024-08-06 First Author Nicholas A Marston
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
Published on 2024-07-22 First Author Marco Valgimigli
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review
Published on 2024-07-18 First Author Subodh Verma
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
Published on 2024-07-11 First Author Ellen M Apperloo
Rivaroxaban Versus Apixaban: A Comparison Without a Simple Solution
Published on 2024-07-08 First Author Marc Cohen
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study
Published on 2024-07-03 First Author Vera A Bittner
Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers
Published on 2024-06-27 First Author Cecilia C Low Wang
Migraine headache in patients with spontaneous coronary artery dissection: A report of the iSCAD Registry
Published on 2024-06-20 First Author Bryan J Wells
Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease
Published on 2024-06-19 First Author Connie N Hess
Association between tissue loss type and amputation risk among Medicare patients with concomitant diabetes and peripheral arterial disease
Published on 2024-06-16 First Author Aravind S Ponukumati
Co-Morbidity Differences Associated With Long-Term Amputation and Repeat Revascularization Rates After Femoropopliteal Artery Intervention for Intermittent Claudication by Sex, Race, and Ethnicity
Published on 2024-06-04 First Author S Elissa Altin
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2024-05-16 First Author Writing Committee Members
Stepping Into the Future of Care for Patients With Peripheral Artery Disease
Published on 2024-05-14 First Author Marc P Bonaca
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2024-05-14 First Author Heather L Gornik
Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment
Published on 2024-05-14 First Author Manasi Tannu
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD
Published on 2024-05-06 First Author Justin T Morrison
Medical Therapy for Peripheral Artery Disease
Published on 2024-05-02 First Author Mario Enrico Canonico
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19
Published on 2024-04-27 First Author Behnood Bikdeli
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Published on 2024-04-24 First Author Shaun G Goodman
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and Atherosclerosis
Published on 2024-04-24 First Author Marc P Bonaca
Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics?
Published on 2024-04-17 First Author Salwa J Zahalka
Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease: Insights from the SCORED randomized trial
Published on 2024-04-17 First Author Rahul Aggarwal
Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography
Published on 2024-04-12 First Author Nick S Nurmohamed
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial
Published on 2024-04-02 First Author Zhong Yuan
Posttraumatic Stress Disorder After Spontaneous Coronary Artery Dissection: A Report of the International Spontaneous Coronary Artery Dissection Registry
Published on 2024-03-27 First Author Jennifer A Sumner
Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl
Published on 2024-03-26 First Author Michael Szarek
The "Woundosome" Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia
Published on 2024-03-25 First Author Lorenzo Patrone
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES
Published on 2024-03-19 First Author Michael Szarek
Methods, design, and initial results of an angiographic core lab from VOYAGER-PAD
Published on 2024-03-17 First Author R Kevin Rogers
Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis
Published on 2024-02-28 First Author Aeron M Small
Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics
Published on 2024-02-21 First Author Shaun G Goodman
Unplanned Index Limb Revascularization With Rivaroxaban Versus Placebo in Patients With Critical Limb-Threatening Ischemia After Endovascular and Surgical Treatment: Insights From VOYAGER PAD
Published on 2024-02-20 First Author Shea E Hogan
Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials
Published on 2024-02-07 First Author John W Eikelboom
Safety and Efficacy of Insulins in Critically Ill Patients Receiving Continuous Enteral Nutrition
Published on 2024-02-02 First Author Kevin Ni
BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally
Published on 2024-01-31 First Author Alik Farber
Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD: A Secondary Analysis of the SCORED Trial
Published on 2024-01-26 First Author Vikas S Sridhar
Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study
Published on 2023-12-26 First Author Layla A Abushamat
Recapturing the Team Approach to Vascular Care
Published on 2023-12-21 First Author Herbert D Aronow
Lipoprotein(a) and Benefit of Antiplatelet Therapy: Insights from the PEGASUS-TIMI 54 Trial
Published on 2023-12-18 First Author Siddharth M Patel
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials
Published on 2023-11-23 First Author Judith Hsia
A methodology of phenotyping ICU patients from EHR data: High-fidelity, personalized, and interpretable phenotypes estimation
Published on 2023-11-20 First Author Yanran Wang
Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis
Published on 2023-11-13 First Author Patrick R Lawler
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c
Published on 2023-11-01 First Author Rahul Aggarwal
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease
Published on 2023-10-27 First Author Ramon L Varcoe
Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD
Published on 2023-10-18 First Author Jennifer Rymer
Long-Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo-Controlled Observation in the ODYSSEY OUTCOMES Trial
Published on 2023-09-13 First Author Shaun G Goodman
Advances in the management of type 2 diabetes in adults
Published on 2023-09-08 First Author Rodolfo J Galindo
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both
Published on 2023-09-04 First Author Marc P Bonaca
A methodology of phenotyping ICU patients from EHR data: high-fidelity, personalized, and interpretable phenotypes estimation
Published on 2023-09-04 First Author Yanran Wang
Initiating Mineralocorticoid Antagonists for Longstanding Heart Failure With Reduced Ejection Fraction: Better Late Than Never?
Published on 2023-08-29 First Author Andrew J Sauer
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Published on 2023-08-26 First Author Michael Szarek
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
Published on 2023-08-23 First Author Jeanine E Roeters van Lennep
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF
Published on 2023-08-09 First Author Bertram Pitt